Alzeca Biosciences Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$11M
- Investors
-
5
Alzeca Biosciences General Information
Description
Developer of advanced imaging agents designed for the diagnosis of Alzheimer's disease and other neurodegenerative disorders. The company's agents are based on nanoparticles that specifically bind to abnormal proteins that accumulate in the brain years before significant cognitive symptoms appear, enabling healthcare providers to easily detect and screen for disorders at a lower cost.
Contact Information
Website
www.alzeca.comCorporate Office
- 1800 Bering Drive
- Suite 850
- Houston, TX 77057
- United States
Corporate Office
- 1800 Bering Drive
- Suite 850
- Houston, TX 77057
- United States
Alzeca Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Later Stage VC (Series A) | 17-Aug-2017 | $11M | 000.00 | 0000 | Completed | Clinical Trials - Phase 1 |
1. Early Stage VC | 30-Nov-2012 | 00000 | 00000 | Completed | Startup |
Alzeca Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Alzeca Biosciences Executive Team (7)
Name | Title | Board Seat |
---|---|---|
Carlo Medici Ph.D | Chief Executive Officer & Board Member | |
Eric Tanifum | Co-Founder | |
Jason Eriksen Ph.D | Co-Founder & Chairman, Scientific Advisory Board | |
Ananth Annapragada Ph.D | Co-Founder, Board Member & Scientific Advisor | |
Peter Working Ph.D | Scientific Advisor |
Alzeca Biosciences Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Ananth Annapragada Ph.D | Self | Co-Founder, Board Member & Scientific Advisor | 000 0000 |
Carlo Medici Ph.D | Alzeca Biosciences | Chief Executive Officer & Board Member | 000 0000 |
Navneet Puri Ph.D | Self | Board Member | 000 0000 |
Peter Werth | Werth Ventures | Board Member | 000 0000 |
Scott Atlas MD | Alzeca Biosciences | Chairman | 000 0000 |
Alzeca Biosciences Signals
Alzeca Biosciences Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Fieldstone Partners | Merchant Banking Firm | Minority | 000 0000 | 000000 0 |
Steve Cook | Angel (individual) | Minority | 000 0000 | 000000 0 |
Werth Ventures | Family Office | Minority | 000 0000 | 000000 0 |
Central Texas Angel Network | Angel Group | Minority | 000 0000 | 000000 0 |
Dolby Family Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Alzeca Biosciences FAQs
-
When was Alzeca Biosciences founded?
Alzeca Biosciences was founded in 2010.
-
Who is the founder of Alzeca Biosciences?
Eric Tanifum, Jason Eriksen Ph.D, Robin Mansukhani, and Ananth Annapragada Ph.D are the founders of Alzeca Biosciences.
-
Who is the CEO of Alzeca Biosciences?
Carlo Medici Ph.D is the CEO of Alzeca Biosciences.
-
Where is Alzeca Biosciences headquartered?
Alzeca Biosciences is headquartered in Houston, TX.
-
What is the size of Alzeca Biosciences?
Alzeca Biosciences has 5 total employees.
-
What industry is Alzeca Biosciences in?
Alzeca Biosciences’s primary industry is Biotechnology.
-
Is Alzeca Biosciences a private or public company?
Alzeca Biosciences is a Private company.
-
What is the current valuation of Alzeca Biosciences?
The current valuation of Alzeca Biosciences is 0000.
-
What is Alzeca Biosciences’s current revenue?
The current revenue for Alzeca Biosciences is 000000.
-
How much funding has Alzeca Biosciences raised over time?
Alzeca Biosciences has raised $11.2M.
-
Who are Alzeca Biosciences’s investors?
Fieldstone Partners, Steve Cook, Werth Ventures, Central Texas Angel Network, and Dolby Family Ventures have invested in Alzeca Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »